{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:18:42Z","timestamp":1775477922240,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017784","name":"Gilead Research Scholars Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jhepr.2026.101771","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:15:52Z","timestamp":1770192952000},"page":"101771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-6591","authenticated-orcid":false,"given":"Margarita","family":"Papatheodoridi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Paraskevopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2583-8710","authenticated-orcid":false,"given":"Panagiota","family":"Ioannidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4084-4593","authenticated-orcid":false,"given":"Paraskevi","family":"Fytili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0082-634X","authenticated-orcid":false,"given":"Dimitrios S.","family":"Karagiannakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6248-6964","authenticated-orcid":false,"given":"Alkistis","family":"Papatheodoridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-6807","authenticated-orcid":false,"given":"Stratigoula","family":"Sakellariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Cholongitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3680-8194","authenticated-orcid":false,"given":"Ioannis","family":"Vlachogiannakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3518-4060","authenticated-orcid":false,"given":"George","family":"Papatheodoridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.101771_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2006-939751","article-title":"Hepatitis Be antigen negative chronic hepatitis B \u2013 natural history and treatment","volume":"26","author":"Hadziyannis","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2026.101771_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1473-3099(07)70264-5","article-title":"Therapeutic strategies in the management of patients with chronic hepatitis B","volume":"8","author":"Papatheodoridis","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhepr.2026.101771_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101771_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2026.101771_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/jvh.13511","article-title":"Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone","volume":"28","author":"Yao","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhepr.2026.101771_bib7","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","article-title":"Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase","volume":"20","author":"Huang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/jvh.13873","article-title":"Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone","volume":"30","author":"Gan","year":"2023","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhepr.2026.101771_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2468-1253(20)30307-1","article-title":"Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis","volume":"6","author":"Tan","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.14218\/JCTH.2021.00443","article-title":"HBeAg-Negative patients with chronic hepatitis B virus infection and normal alanine aminotransferase: wait or treat?","volume":"10","author":"Sheng","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib11","unstructured":"World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. https:\/\/www.who.int\/publications\/i\/item\/9789240090903.2024.March.29."},{"key":"10.1016\/j.jhepr.2026.101771_bib12","first-page":"1425","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"11","author":"You","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2024.11.018","article-title":"Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: a systematic review and meta-analysis","volume":"82","author":"Lai","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jhep.2011.11.030","article-title":"Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review","volume":"57","author":"Papatheodoridis","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib18","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/liv.13416","article-title":"Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: benign course towards HBsAg clearance","volume":"37","author":"Oliveri","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2026.101771_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/apt.14613","article-title":"Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone","volume":"47","author":"Bonacci","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2026.101771_bib20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.14309\/ajg.0000000000000400","article-title":"Phase transition is infrequent among North American adults with e-antigen-negative chronic hepatitis B and low-level viremia","volume":"114","author":"Zhou","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101771_bib21","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/hep.31554","article-title":"Low incidence of adverse outcomes in adults with chronic hepatitis B virus infection in the era of antiviral therapy","volume":"73","author":"Lok","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101771_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/apt.70194","article-title":"Distribution, characteristics, and natural history of diverse types of indeterminate chronic hepatitis B: a REAL-B study","volume":"62","author":"Huang","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2026.101771_bib23","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/gutjnl-2025-335033","article-title":"Differential HCC risk among HBV indeterminate types at baseline and by phase transition","volume":"74","author":"Huang","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2026.101771_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/HEP.0000000000001354","article-title":"Increased risk of HCC in HBeAg-negative indeterminate phase compared with HBeAg-negative chronic infection","volume":"83","author":"Hui","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101771_bib25","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/hep.22518","article-title":"Is there a meaningful serum HBV DNA cut-off level for therapeutic decisions in HBeAg-negative chronic hepatitis B virus infection?","volume":"48","author":"Papatheodoridis","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101771_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4254\/wjh.v16.i6.920","article-title":"Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase","volume":"16","author":"Huang","year":"2024","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101771_bib27","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","year":"2025","journal-title":"J Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592600042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592600042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:38:50Z","timestamp":1775475530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592600042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S258955592600042X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101771","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101771"}}